Lv41
586 积分 2025-01-07 加入
Nonclinical Absorption, Distribution, Metabolism, Excretion and Biomarkers Properties of a Modified N-Acetylgalactosamine–Conjugated Small Interfering RNA for Hypercholesteremia
4天前
求助中
Nonclinical Pharmacokinetics and Absorption, Distribution, Metabolism, and Excretion of Givosiran, the First Approved N-Acetylgalactosamine–Conjugated RNA Interference Therapeutic
4天前
已完结
Preclinical and Clinical Drug-metabolism, Pharmacokinetics and Safety of Therapeutic Oligonucleotides
4天前
已完结
Guidelines for the management of hemophilia
11天前
已完结
An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia
24天前
已完结
Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia A
25天前
已完结
RNAi-based drug design: considerations and future directions
1个月前
已完结
Strategies for Organ‐Targeted mRNA Delivery by Lipid Nanoparticles
1个月前
已完结
Mechanistic insights into interactions between ionizable lipid nanodroplets and biomembranes
1个月前
已完结
Lipid nanoparticle-based strategies for extrahepatic delivery of nucleic acid therapies – challenges and opportunities
1个月前
已完结
皖公网安备34019202002308
